Tag: Pharma Geo Competition

  • Geo-Competition, RWE, and the Global Policy Storm

    Geo-Competition, RWE, and the Global Policy Storm

    —

    by

    wlcus_admin
    in

    Pharma Market Access in 2025: Geo-Competition, RWE, and the Global Policy Storm In 2025, pharma market access is no longer just about clinical evidence and pricing. It’s now a geopolitical chessboard—where real-world evidence (RWE), health technology assessment (HTA), and policy shifts like U.S. tariffs are shaping which medicines reach patients and how fast. Join us…